1. Home
  2. DERM vs LARK Comparison

DERM vs LARK Comparison

Compare DERM & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • LARK
  • Stock Information
  • Founded
  • DERM 2014
  • LARK 1885
  • Country
  • DERM United States
  • LARK United States
  • Employees
  • DERM N/A
  • LARK N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • LARK Major Banks
  • Sector
  • DERM Health Care
  • LARK Finance
  • Exchange
  • DERM Nasdaq
  • LARK Nasdaq
  • Market Cap
  • DERM 181.0M
  • LARK 167.5M
  • IPO Year
  • DERM 2021
  • LARK N/A
  • Fundamental
  • Price
  • DERM $6.28
  • LARK $25.18
  • Analyst Decision
  • DERM Strong Buy
  • LARK
  • Analyst Count
  • DERM 2
  • LARK 0
  • Target Price
  • DERM $10.00
  • LARK N/A
  • AVG Volume (30 Days)
  • DERM 104.8K
  • LARK 13.0K
  • Earning Date
  • DERM 08-11-2025
  • LARK 08-04-2025
  • Dividend Yield
  • DERM N/A
  • LARK 3.36%
  • EPS Growth
  • DERM N/A
  • LARK 27.69
  • EPS
  • DERM N/A
  • LARK 2.59
  • Revenue
  • DERM $56,243,000.00
  • LARK $60,798,000.00
  • Revenue This Year
  • DERM $28.99
  • LARK N/A
  • Revenue Next Year
  • DERM $52.61
  • LARK N/A
  • P/E Ratio
  • DERM N/A
  • LARK $9.73
  • Revenue Growth
  • DERM N/A
  • LARK 9.30
  • 52 Week Low
  • DERM $3.54
  • LARK $17.86
  • 52 Week High
  • DERM $8.25
  • LARK $31.04
  • Technical
  • Relative Strength Index (RSI)
  • DERM 38.72
  • LARK 24.93
  • Support Level
  • DERM $6.29
  • LARK $26.20
  • Resistance Level
  • DERM $7.13
  • LARK $29.38
  • Average True Range (ATR)
  • DERM 0.41
  • LARK 0.83
  • MACD
  • DERM -0.15
  • LARK -0.37
  • Stochastic Oscillator
  • DERM 3.31
  • LARK 2.69

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

Share on Social Networks: